In patients with acromegaly, trabecular and cortical microarchitectural alterations and an increased risk of fractures persist even after achieving biochemical control of the GH/IGF-1 axis, indicating long-term impairment of bone quality that may be relevant for primary and secondary implant stability [9]. The gene discussed is IGF1; the disease is acromegaly.